Advertisement
Clinical communication to the Editor| Volume 119, ISSUE 3, e3-e5, March 2006

Bilateral Adrenal Adenomas and Persistent Leukocytosis: A Unique Case of Cushing’s Syndrome

      To the Editor:
      Cushing’s syndrome is a constellation of signs and symptoms due to glucocorticoid excess. Most commonly it results from chronic glucocorticoid therapy. The main cause of spontaneous Cushing’s syndrome (60-70% of cases), also known as Cushing’s disease, is a pituitary adenoma secreting adrenocorticotropic hormone. Fifteen to 20% of cases of Cushing’s syndrome are due to ectopic adrenocorticotropic hormone secretion from nonpituitary tumors, whereas 10% of cases are due to glucocorticoid production from adrenal tumors.
      • Aron D.C.
      • Findling J.W.
      • Tyrell J.B.
      Glucocrticoids and adrenal androgens.
      Rare causes of Cushing’s syndrome include corticotrophin-releasing hormone (CRH)-producing tumors, bilateral macronodular adrenal hyperplasia, and primary pigmented nodular disease. Total white blood cell count is usually normal in Cushing’s syndrome with low eosinophil and lymphocyte counts, although granulocytes may be mildly increased.
      • Aron D.C.
      • Findling J.W.
      • Tyrell J.B.
      Glucocrticoids and adrenal androgens.
      Herein we report a case of Cushing’s syndrome due to bilateral adrenal adenoma initially presenting only as persistent leukocytosis.

      Case report

      A 30-year-old white woman presented to her primary care physician in August 2003 for fatigue of 1 month’s duration. She had an elevated white blood cell count (14.4 × 109/L) and was found to have urinary tract infection and an ear infection for which she was treated with antibiotics. Since leukocytosis persisted even after treatment, she was referred to the hematology service in September 2003. Her past medical history was significant for polycystic ovary syndrome, frequent vaginal yeast infections, recurrent urinary tract infections, and left axillary sebaceous cyst infections. HIV and diabetes mellitus were ruled out by appropriate testing in the past. She had been taking metformin for approximately 1 year for polycystic ovary syndrome. Her family history included familial adenomatous polyposis of the colon in her father and brother. Her mother died at age 19 from Hodgkin’s disease.
      During hematological evaluation, her white blood cell count was 19.2 × 109/L with normal differentiation; hemoglobin and hematocrit were 16.2 g/dL and 48.9%, respectively. She denied any symptoms except persistent fatigue, and her physical examination was unremarkable. On further testing, blood glucose was 84 mg/dL, serum Na 140 mmol/L, and K 4.4 mmol/L. Blood and urine cultures, chest radiograph, and purified protein derivative test were negative. Her bone marrow aspiration and biopsy revealed no evidence of any hematological problem. Computed tomography (CT) scans of the chest and abdomen revealed a heterogeneous solid nodule in each adrenal gland. Her random serum cortisol levels were 26.2 microg/dL (11 am) and 22.3 microg/dL (4 pm). She was then referred to the endocrinology service in November 2003.
      At presentation to the endocrinology service, she complained of persistent fatigue as well as new symptoms of abdominal cramping, bloating, and weight gain. On examination, blood pressure was 140/90, and heart rate was 96 beats per minute. She had a round face, acne, hirsutism, and pink abdominal striae. There were no bruises or dorso- cervical fat pad. Following the administration of 1 mg dexamethasone at 11 pm, serum cortisol was 24.7 μg/dL the following morning. Other test results are shown in the Table.
      TableEndocrinology Evaluation
      ExaminationPatient’s Values (Normal Values)
      24-h urine free cortisol227.5 (5-50 μg/24 h)
      24-h urine 17-ketosteroids7.8 (5-15 mg/24 h)
      24-h urine 17-OH-corticosteroids12.8 (3-10 mg/24 h)
      Serum TSH0.40 (0.4-5.5 mU/L)
      Serum Total T46.7 (4.5-12.0 μg/dL)
      Serum FSH4.1 (1.5-18.8 mIU/mL)
      Serum LH7.6 (1.9-76.3 mIUm/L)
      Serum total testosterone28 (15-70 ng/dL)
      Serum free testosterone5.6 (1.0-8.5 pg/mL)
      TSH = thyroid-stimulating hormone; FSH = follicle-stimulating hormone; LH = luteinizing hormone.
      Pseudo Cushing’s syndrome was ruled out by Dexamethasone-CRH test.
      • Yanovski J.A.
      • Cutler Jr, G.B.
      • Chrousos G.P.
      • et al.
      Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration.
      Random adrenocorticotropic hormone level was 2 pg/mL, and simultaneous serum cortisol was 39.8 μg/dL, consistent with an adrenocorticotropic hormone-independent cause of hypercortisolism. Magnetic resonance imaging study of the abdomen showed bilateral adrenal nodules, 2 × 3 × 2.5 cm on the left and 2 × 1.9 × 1.6 cm on the right (Figure 1). Both adrenal nodules demonstrated <50% signal drop on the out-of-phase images, consistent with bilateral adrenal adenomas. On iodocholesterol scanning, abnormal radiotracer uptake was seen in both adrenal glands, consistent with bilateral functioning adrenal cortical adenoma
      • Barzon L.
      • Boscara M.
      Diagnosis and management of adrenal incidentalomas.
      (Figure 2).
      Figure thumbnail gr1
      Figure 1MRI showing bilateral adrenal adenoma.
      Figure thumbnail gr2
      Figure 2Iodocholesterol scan (posterior view) showing bilateral adrenal uptake.
      The patient underwent laparoscopic bilateral adrenalectomy in April 2004. Surgical pathology showed bilateral adrenal adenoma with atrophy of attached cortex, consistent with suppression of adrenocorticotropic hormone. There were no features of malignancy (Figure 3). Both nodules were well circumscribed and yellow/tan in color. Postoperative baseline serum cortisol level was undetectable, suggesting cure of Cushing’s syndrome. By June 2004, her white blood cell count returned to normal.
      Figure thumbnail gr3
      Figure 3Hematoxylin-and-eosin-stained tissue sections of left adrenal gland (A) and right adrenal gland (B) demonstrate bilateral tumor nodules and atrophic non-tumorous adrenal tissue (50×).

      Discussion

      This case is unique, as the patient presented only with persistent leukocytosis (with normal differential count). She initially denied common symptoms of Cushing’s syndrome except chronic fatigue and frequent infection. She had no stigmata of Cushing’s syndrome on initial clinical examination. She developed classic features of Cushing’s syndrome later on during her evaluation for bilateral adrenal masses.
      Bilateral functioning adrenal adenomas are very rare. Only 25 cases have been reported since 1977.
      • Nomura K.
      • Saito H.
      • Aiba M.
      • Iihara M.
      • Obara T.
      • Takano K.
      Cushing’s syndrome due to bilateral adrenocortical adenomas with unique histological features.
      There are several forms of adrenocorticotropic hormone-dependent and -independent bilateral adrenal hyperplasia. Simple adrenocortical hyperplasia due to Cushing’s disease (adrenocorticotropic hormone-dependent) is the most common. On histology, there is equal hyperplasia of clear cells of the zona fasciculata and compact cells of the zona reticularis.
      • Maitra A.
      • Abbas A.K.
      The endocrine system.
      Abnormal adrenal expression of receptors for a variety of hormones (like gastric inhibitory peptide) can lead to adrenocorticotropic hormone-independent bilateral macronodular adrenal hyperplasia (AIMAH)
      • Reznik Y.
      • Allali-Zerah V.
      • Chayvialle J.
      • et al.
      Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory peptide.
      In AIMAH, the nodules are multiple, not encapsulated, and the adjacent area is hypertrophic.
      • Makino S.
      • Chikazawa H.
      • Yorimitsu A.
      • et al.
      A rare case of Cushing’s syndrome due to bilateral adrenocortical adenomas.
      Cortisol- producing primary adrenal adenomas are usually single, unilateral and encapsulated. It is usually associated with suppressed adrenocorticotropic hormone levels leading to atrophy of the adjacent non-nodular area and uninvolved gland.
      • Maitra A.
      • Abbas A.K.
      The endocrine system.
      Surgical specimens in this case showed bilateral, well-circumscribed yellow/tan nodules arising from the parenchyma with atrophy of attached cortex. This is consistent with bilateral adrenal adenomas. Primary pigmented nodular adrenocortical disease is another rare cause of bilateral adrenal hyperplasia. It is an autosomal dominant disease of young age. It is associated with the Carney complex-cardiac, cutaneous, and mammary myxomas, spotty facial skin pigmentation, testicular tumors, acromegaly, Schwannomas, and thyroid nodules.
      • Stratakis C.A.
      Clinical and molecular features of the Carney complex diagnostic criteria and recommendations for patient evaluation.
      The adrenal glands in primary pigmented nodular adrenocortical disease demonstrate diffuse darkly pigmented (brown to black) bilateral micronodules.
      • Maitra A.
      • Abbas A.K.
      The endocrine system.
      In conclusion, Cushing’s syndrome should be considered in the differential diagnosis of unexplained persistent leukocytosis.

      Acknowledgment

      We would like to thank Dr. Harold Carlson for reviewing the manuscript.

      References

        • Aron D.C.
        • Findling J.W.
        • Tyrell J.B.
        Glucocrticoids and adrenal androgens.
        in: Greenspan F. Gardner D.G. Basic and Clinical Endocrinology. 7th ed. Lange, New York, NY2001: 362
        • Yanovski J.A.
        • Cutler Jr, G.B.
        • Chrousos G.P.
        • et al.
        Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration.
        JAMA. 1993; 269: 2232-2238
        • Barzon L.
        • Boscara M.
        Diagnosis and management of adrenal incidentalomas.
        J Urol. 2000; 163: 398-422
        • Nomura K.
        • Saito H.
        • Aiba M.
        • Iihara M.
        • Obara T.
        • Takano K.
        Cushing’s syndrome due to bilateral adrenocortical adenomas with unique histological features.
        Endocr J. 2003; 50: 155-162
        • Maitra A.
        • Abbas A.K.
        The endocrine system.
        in: Kumar V. Abbas A.K. Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Elsevier, Philadelphia, Penn2005: 1155
        • Reznik Y.
        • Allali-Zerah V.
        • Chayvialle J.
        • et al.
        Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory peptide.
        N Engl J Med. 1992; 327: 981-986
        • Makino S.
        • Chikazawa H.
        • Yorimitsu A.
        • et al.
        A rare case of Cushing’s syndrome due to bilateral adrenocortical adenomas.
        Endocr J. 1997; 44: 533-540
        • Stratakis C.A.
        Clinical and molecular features of the Carney complex.
        J Clin Endocrinol Metab. 2001; 86: 4041-4046